Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $956.70 | 58 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $121.90 | 9 | $0 (2024) |
| PFIZER INC. | $119.07 | 8 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $118.62 | 7 | $0 (2024) |
| ATRICURE, INC. | $91.72 | 4 | $0 (2023) |
| Merck Sharp & Dohme LLC | $89.55 | 6 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $80.92 | 6 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $76.29 | 3 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $71.58 | 5 | $0 (2024) |
| Edwards Lifesciences Corporation | $38.21 | 1 | $0 (2022) |
| Amgen Inc. | $26.79 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $108.89 | 7 | PFIZER INC. ($29.89) |
| 2023 | $432.11 | 24 | ATRICURE, INC. ($91.72) |
| 2022 | $279.77 | 17 | PFIZER INC. ($43.86) |
| 2021 | $135.93 | 10 | AstraZeneca Pharmaceuticals LP ($40.88) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/17/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Genetic Disease | ||||||
| 04/02/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/22/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Cardiology | ||||||
| 02/09/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/02/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/26/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/07/2023 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/13/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/11/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/25/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/18/2023 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device), EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/13/2023 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $41.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/12/2023 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/29/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: DIABETES | ||||||
| 08/21/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Cardiology | ||||||
| 07/13/2023 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Genetic Disease | ||||||
| 06/12/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Food and Beverage | Cash or cash equivalent | $17.53 | General |
| Category: Cardiovascular Device | ||||||
| 06/09/2023 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Genetic Disease | ||||||
| 05/17/2023 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Genetic Disease | ||||||
| 05/11/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/19/2023 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device), ATRICLIP LAA EXCLUSION SYSTEM | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/17/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $44.94 | General |
| Category: DIABETES | ||||||
| 04/14/2023 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Genetic Disease | ||||||
| 04/12/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 1,792 | 2,183 | $265,151 | $93,266 |
| 2022 | 9 | 1,786 | 2,338 | $287,598 | $99,051 |
| 2021 | 10 | 1,695 | 2,113 | $249,664 | $92,313 |
| 2020 | 5 | 492 | 590 | $46,153 | $16,896 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 883 | 1,164 | $186,240 | $79,345 | 42.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 507 | 578 | $52,020 | $4,539 | 8.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 51 | 51 | $12,546 | $4,360 | 34.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 253 | 289 | $5,780 | $2,388 | 41.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 19 | $2,033 | $938.21 | 46.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 49 | 52 | $2,754 | $682.24 | 24.8% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 15 | 15 | $2,473 | $648.62 | 26.2% |
| 85576 | Platelet aggregation function test | Office | 2023 | 15 | 15 | $1,305 | $366.15 | 28.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 882 | 1,224 | $195,840 | $84,344 | 43.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 59 | 59 | $14,514 | $5,147 | 35.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 542 | 636 | $57,240 | $4,865 | 8.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 11 | 79 | $9,638 | $2,399 | 24.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 220 | 266 | $5,320 | $767.93 | 14.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 12 | $1,284 | $562.85 | 43.8% |
| 85576 | Platelet aggregation function test | Office | 2022 | 19 | 19 | $1,653 | $451.58 | 27.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 29 | 31 | $1,581 | $384.15 | 24.3% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2022 | 12 | 12 | $528.00 | $129.66 | 24.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 780 | 1,065 | $170,400 | $78,293 | 45.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 449 | 518 | $46,620 | $4,268 | 9.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 37 | 37 | $9,102 | $3,820 | 42.0% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2021 | 38 | 41 | $6,560 | $1,577 | 24.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 31 | 34 | $3,638 | $1,444 | 39.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 260 | 317 | $6,340 | $944.00 | 14.9% |
| 85576 | Platelet aggregation function test | Office | 2021 | 29 | 30 | $2,610 | $747.30 | 28.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 20 | 20 | $1,945 | $708.21 | 36.4% |
About Brandon Petty
Brandon Petty is a Nurse Practitioner healthcare provider based in Tupelo, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/06/2019. The National Provider Identifier (NPI) number assigned to this provider is 1073157715.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brandon Petty has received a total of $956.70 in payments from pharmaceutical and medical device companies, with $108.89 received in 2024. These payments were reported across 58 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($956.70).
As a Medicare-enrolled provider, Petty has provided services to 5,765 Medicare beneficiaries, totaling 7,224 services with total Medicare billing of $301,527. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Tupelo, MS
- Active Since 11/06/2019
- Last Updated 11/06/2019
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1073157715
Products in Payments
- FARXIGA (Drug) $93.27
- VERQUVO (Drug) $89.55
- ONPATTRO (Drug) $80.08
- JARDIANCE (Drug) $76.29
- ELIQUIS (Drug) $75.21
- XARELTO (Drug) $71.58
- LEQVIO (Drug) $57.95
- SYNERGY ABLATION SYSTEM (Device) $49.73
- VYNDAQEL (Drug) $43.86
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $41.99
- AMVUTTRA (Drug) $38.54
- SAPIEN 3 Ultra RESILIA (Device) $38.21
- WAINUA (Drug) $28.63
- Repatha (Biological) $26.79
- ENTRESTO (Drug) $22.97
- ZIO XT Patch (Device) $20.17
- Vascepa (Drug) $19.10
- NEXLETOL (Drug) $19.09
- OPTIMIZER (Device) $17.53
- BVA-100 (Device) $16.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Tupelo
Sara Harrington, Agnp-C, AGNP-C
Nurse Practitioner — Payments: $9,971
Katelyn Boren
Nurse Practitioner — Payments: $7,802
Janice Driskell, Np, NP
Nurse Practitioner — Payments: $5,637
Mrs. Stephanie Atkinson, N.p, N.P
Nurse Practitioner — Payments: $4,776
Jennifer Rossi, Pmhnp, PMHNP
Nurse Practitioner — Payments: $2,918
Mr. James Call, Fnp-C, FNP-C
Nurse Practitioner — Payments: $2,519